➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Mallinckrodt
Colorcon
Express Scripts
Boehringer Ingelheim

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

Actavis Llc Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ACTAVIS LLC, and what generic and branded alternatives to ACTAVIS LLC drugs are available?

ACTAVIS LLC has eleven approved drugs.

There are two tentative approvals on ACTAVIS LLC drugs.

Drugs and US Patents for Actavis Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Llc MELPHALAN HYDROCHLORIDE melphalan hydrochloride POWDER;INTRAVENOUS 209323-001 Mar 6, 2020 DISCN No No   Start Trial   Start Trial
Actavis Llc OXALIPLATIN oxaliplatin INJECTABLE;INTRAVENOUS 204880-001 Mar 5, 2018 AP RX No No   Start Trial   Start Trial
Actavis Llc DAPSONE dapsone TABLET;ORAL 204380-001 Mar 23, 2017 AB RX No No   Start Trial   Start Trial
Actavis Llc DOCETAXEL docetaxel INJECTABLE;INJECTION 203551-004 Sep 21, 2015 AP RX No No   Start Trial   Start Trial
Actavis Llc HYDROXOCOBALAMIN hydroxocobalamin INJECTABLE;INJECTION 085998-001 Approved Prior to Jan 1, 1982 RX No Yes   Start Trial   Start Trial
Actavis Llc MELPHALAN HYDROCHLORIDE melphalan hydrochloride INJECTABLE;INJECTION 206018-001 Dec 19, 2016 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Mallinckrodt
Baxter
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.